1. Home
  2. CRSP vs SLAB Comparison

CRSP vs SLAB Comparison

Compare CRSP & SLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • SLAB
  • Stock Information
  • Founded
  • CRSP 2013
  • SLAB 1996
  • Country
  • CRSP Switzerland
  • SLAB United States
  • Employees
  • CRSP N/A
  • SLAB N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • SLAB Semiconductors
  • Sector
  • CRSP Health Care
  • SLAB Technology
  • Exchange
  • CRSP Nasdaq
  • SLAB Nasdaq
  • Market Cap
  • CRSP 5.6B
  • SLAB 4.7B
  • IPO Year
  • CRSP 2016
  • SLAB 2000
  • Fundamental
  • Price
  • CRSP $52.57
  • SLAB $121.75
  • Analyst Decision
  • CRSP Buy
  • SLAB Buy
  • Analyst Count
  • CRSP 19
  • SLAB 11
  • Target Price
  • CRSP $71.94
  • SLAB $144.00
  • AVG Volume (30 Days)
  • CRSP 2.5M
  • SLAB 287.9K
  • Earning Date
  • CRSP 11-10-2025
  • SLAB 11-04-2025
  • Dividend Yield
  • CRSP N/A
  • SLAB N/A
  • EPS Growth
  • CRSP N/A
  • SLAB N/A
  • EPS
  • CRSP N/A
  • SLAB N/A
  • Revenue
  • CRSP $38,337,000.00
  • SLAB $742,807,000.00
  • Revenue This Year
  • CRSP N/A
  • SLAB $37.60
  • Revenue Next Year
  • CRSP $391.94
  • SLAB $19.26
  • P/E Ratio
  • CRSP N/A
  • SLAB N/A
  • Revenue Growth
  • CRSP N/A
  • SLAB 47.10
  • 52 Week Low
  • CRSP $30.04
  • SLAB $82.82
  • 52 Week High
  • CRSP $78.48
  • SLAB $160.00
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 34.88
  • SLAB 37.03
  • Support Level
  • CRSP $52.42
  • SLAB $125.59
  • Resistance Level
  • CRSP $58.48
  • SLAB $131.50
  • Average True Range (ATR)
  • CRSP 3.56
  • SLAB 5.18
  • MACD
  • CRSP -1.14
  • SLAB -0.89
  • Stochastic Oscillator
  • CRSP 21.64
  • SLAB 8.41

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

Share on Social Networks: